Takeda Pharmaceutical Co., Ltd.

19
Strong Sell
  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3463000004
JPY
5,087.00
33 (0.65%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Takeda Pharmaceutical Co., Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
No of Months
12
12
12
12
12
12
Profit Before Tax
-140,178.00
179,070.00
46,318.00
383,720.00
317,938.00
366,159.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
152,623.00
-69,479.00
-263,559.00
-114,042.00
140,014.00
313,567.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
938,708.00
962,493.00
640,321.00
877,217.00
1,021,218.00
905,073.00
Cash Flow from Investing Activities
-387,798.00
-385,355.00
-488,214.00
-615,718.00
-204,445.00
392,038.00
Cash Flow from Financing Activities
-375,440.00
-638,441.00
-254,041.00
-600,593.00
-962,058.00
-981,004.00
Net Cash Inflow / Outflow
209,942.00
-72,688.00
-75,730.00
-316,165.00
-116,527.00
328,608.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
34,472.00
-11,385.00
26,204.00
22,929.00
28,758.00
12,501.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in JPY Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Takeda Pharmaceutical Co., Ltd.
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
Profit Before Tax
-140178
597807
-7,37,985.00
-123.45%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
152623
-79651
2,32,274.00
291.61%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
938708
389451
5,49,257.00
141.03%
Cash Flow from Investing Activities
-387798
-204873
-1,82,925.00
-89.29%
Cash Flow from Financing Activities
-375440
-307457
-67,983.00
-22.11%
Net Cash Inflow / Outflow
209942
-113600
3,23,542.00
284.81%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
34472
9279
25,193.00
271.51%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Mar'26
stock-summary

YoY Growth in year ended Mar 2026 is -2.47% vs 50.31% in Mar 2025

Mar'26
Mar'25
Change(%)
Cash Flow from Operating Activities
9,38,708.00
9,62,493.00
-2.47%